Global Vials for COVID-19 Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Vials for COVID-19 Vaccine market size was valued at US$ million in 2023. With growing demand in downstream market, the Vials for COVID-19 Vaccine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Vials for COVID-19 Vaccine market. Vials for COVID-19 Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Vials for COVID-19 Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Vials for COVID-19 Vaccine market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Vials for COVID-19 Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Vials for COVID-19 Vaccine market. It may include historical data, market segmentation by Type (e.g., Middle-borate Borosilicate Glass, Low-borate Borosilicate Glass), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Vials for COVID-19 Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Vials for COVID-19 Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Vials for COVID-19 Vaccine industry. This include advancements in Vials for COVID-19 Vaccine technology, Vials for COVID-19 Vaccine new entrants, Vials for COVID-19 Vaccine new investment, and other innovations that are shaping the future of Vials for COVID-19 Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Vials for COVID-19 Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Vials for COVID-19 Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Vials for COVID-19 Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Vials for COVID-19 Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Vials for COVID-19 Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Vials for COVID-19 Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Vials for COVID-19 Vaccine market.
Market Segmentation:
Vials for COVID-19 Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Vials for COVID-19 Vaccine market?
What factors are driving Vials for COVID-19 Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vials for COVID-19 Vaccine market opportunities vary by end market size?
How does Vials for COVID-19 Vaccine break out type, application?
According to our LPI (LP Information) latest study, the global Vials for COVID-19 Vaccine market size was valued at US$ million in 2023. With growing demand in downstream market, the Vials for COVID-19 Vaccine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Vials for COVID-19 Vaccine market. Vials for COVID-19 Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Vials for COVID-19 Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Vials for COVID-19 Vaccine market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Vials for COVID-19 Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Vials for COVID-19 Vaccine market. It may include historical data, market segmentation by Type (e.g., Middle-borate Borosilicate Glass, Low-borate Borosilicate Glass), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Vials for COVID-19 Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Vials for COVID-19 Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Vials for COVID-19 Vaccine industry. This include advancements in Vials for COVID-19 Vaccine technology, Vials for COVID-19 Vaccine new entrants, Vials for COVID-19 Vaccine new investment, and other innovations that are shaping the future of Vials for COVID-19 Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Vials for COVID-19 Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Vials for COVID-19 Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Vials for COVID-19 Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Vials for COVID-19 Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Vials for COVID-19 Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Vials for COVID-19 Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Vials for COVID-19 Vaccine market.
Market Segmentation:
Vials for COVID-19 Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Middle-borate Borosilicate Glass
- Low-borate Borosilicate Glass
- Vaccine Manufacturing
- Vaccine Researching
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Corning
- Schott AG
- SiO2 Materials Science
- SGD Pharma
- Stevanato Group
- DWK Life Sciences
- Gerresheimer
What is the 10-year outlook for the global Vials for COVID-19 Vaccine market?
What factors are driving Vials for COVID-19 Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vials for COVID-19 Vaccine market opportunities vary by end market size?
How does Vials for COVID-19 Vaccine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vials for COVID-19 Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Vials for COVID-19 Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Vials for COVID-19 Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Vials for COVID-19 Vaccine Segment by Type
2.2.1 Middle-borate Borosilicate Glass
2.2.2 Low-borate Borosilicate Glass
2.3 Vials for COVID-19 Vaccine Sales by Type
2.3.1 Global Vials for COVID-19 Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Vials for COVID-19 Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Vials for COVID-19 Vaccine Sale Price by Type (2019-2024)
2.4 Vials for COVID-19 Vaccine Segment by Application
2.4.1 Vaccine Manufacturing
2.4.2 Vaccine Researching
2.5 Vials for COVID-19 Vaccine Sales by Application
2.5.1 Global Vials for COVID-19 Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Vials for COVID-19 Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Vials for COVID-19 Vaccine Sale Price by Application (2019-2024)
3 GLOBAL VIALS FOR COVID-19 VACCINE BY COMPANY
3.1 Global Vials for COVID-19 Vaccine Breakdown Data by Company
3.1.1 Global Vials for COVID-19 Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Vials for COVID-19 Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Vials for COVID-19 Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Vials for COVID-19 Vaccine Revenue by Company (2019-2024)
3.2.2 Global Vials for COVID-19 Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Vials for COVID-19 Vaccine Sale Price by Company
3.4 Key Manufacturers Vials for COVID-19 Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vials for COVID-19 Vaccine Product Location Distribution
3.4.2 Players Vials for COVID-19 Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VIALS FOR COVID-19 VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Vials for COVID-19 Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Vials for COVID-19 Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Vials for COVID-19 Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Vials for COVID-19 Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Vials for COVID-19 Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Vials for COVID-19 Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Vials for COVID-19 Vaccine Sales Growth
4.4 APAC Vials for COVID-19 Vaccine Sales Growth
4.5 Europe Vials for COVID-19 Vaccine Sales Growth
4.6 Middle East & Africa Vials for COVID-19 Vaccine Sales Growth
5 AMERICAS
5.1 Americas Vials for COVID-19 Vaccine Sales by Country
5.1.1 Americas Vials for COVID-19 Vaccine Sales by Country (2019-2024)
5.1.2 Americas Vials for COVID-19 Vaccine Revenue by Country (2019-2024)
5.2 Americas Vials for COVID-19 Vaccine Sales by Type
5.3 Americas Vials for COVID-19 Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vials for COVID-19 Vaccine Sales by Region
6.1.1 APAC Vials for COVID-19 Vaccine Sales by Region (2019-2024)
6.1.2 APAC Vials for COVID-19 Vaccine Revenue by Region (2019-2024)
6.2 APAC Vials for COVID-19 Vaccine Sales by Type
6.3 APAC Vials for COVID-19 Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vials for COVID-19 Vaccine by Country
7.1.1 Europe Vials for COVID-19 Vaccine Sales by Country (2019-2024)
7.1.2 Europe Vials for COVID-19 Vaccine Revenue by Country (2019-2024)
7.2 Europe Vials for COVID-19 Vaccine Sales by Type
7.3 Europe Vials for COVID-19 Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vials for COVID-19 Vaccine by Country
8.1.1 Middle East & Africa Vials for COVID-19 Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Vials for COVID-19 Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Vials for COVID-19 Vaccine Sales by Type
8.3 Middle East & Africa Vials for COVID-19 Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vials for COVID-19 Vaccine
10.3 Manufacturing Process Analysis of Vials for COVID-19 Vaccine
10.4 Industry Chain Structure of Vials for COVID-19 Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vials for COVID-19 Vaccine Distributors
11.3 Vials for COVID-19 Vaccine Customer
12 WORLD FORECAST REVIEW FOR VIALS FOR COVID-19 VACCINE BY GEOGRAPHIC REGION
12.1 Global Vials for COVID-19 Vaccine Market Size Forecast by Region
12.1.1 Global Vials for COVID-19 Vaccine Forecast by Region (2025-2030)
12.1.2 Global Vials for COVID-19 Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vials for COVID-19 Vaccine Forecast by Type
12.7 Global Vials for COVID-19 Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Corning
13.1.1 Corning Company Information
13.1.2 Corning Vials for COVID-19 Vaccine Product Portfolios and Specifications
13.1.3 Corning Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Corning Main Business Overview
13.1.5 Corning Latest Developments
13.2 Schott AG
13.2.1 Schott AG Company Information
13.2.2 Schott AG Vials for COVID-19 Vaccine Product Portfolios and Specifications
13.2.3 Schott AG Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Schott AG Main Business Overview
13.2.5 Schott AG Latest Developments
13.3 SiO2 Materials Science
13.3.1 SiO2 Materials Science Company Information
13.3.2 SiO2 Materials Science Vials for COVID-19 Vaccine Product Portfolios and Specifications
13.3.3 SiO2 Materials Science Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 SiO2 Materials Science Main Business Overview
13.3.5 SiO2 Materials Science Latest Developments
13.4 SGD Pharma
13.4.1 SGD Pharma Company Information
13.4.2 SGD Pharma Vials for COVID-19 Vaccine Product Portfolios and Specifications
13.4.3 SGD Pharma Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 SGD Pharma Main Business Overview
13.4.5 SGD Pharma Latest Developments
13.5 Stevanato Group
13.5.1 Stevanato Group Company Information
13.5.2 Stevanato Group Vials for COVID-19 Vaccine Product Portfolios and Specifications
13.5.3 Stevanato Group Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Stevanato Group Main Business Overview
13.5.5 Stevanato Group Latest Developments
13.6 DWK Life Sciences
13.6.1 DWK Life Sciences Company Information
13.6.2 DWK Life Sciences Vials for COVID-19 Vaccine Product Portfolios and Specifications
13.6.3 DWK Life Sciences Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 DWK Life Sciences Main Business Overview
13.6.5 DWK Life Sciences Latest Developments
13.7 Gerresheimer
13.7.1 Gerresheimer Company Information
13.7.2 Gerresheimer Vials for COVID-19 Vaccine Product Portfolios and Specifications
13.7.3 Gerresheimer Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Gerresheimer Main Business Overview
13.7.5 Gerresheimer Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vials for COVID-19 Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Vials for COVID-19 Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Vials for COVID-19 Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Vials for COVID-19 Vaccine Segment by Type
2.2.1 Middle-borate Borosilicate Glass
2.2.2 Low-borate Borosilicate Glass
2.3 Vials for COVID-19 Vaccine Sales by Type
2.3.1 Global Vials for COVID-19 Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Vials for COVID-19 Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Vials for COVID-19 Vaccine Sale Price by Type (2019-2024)
2.4 Vials for COVID-19 Vaccine Segment by Application
2.4.1 Vaccine Manufacturing
2.4.2 Vaccine Researching
2.5 Vials for COVID-19 Vaccine Sales by Application
2.5.1 Global Vials for COVID-19 Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Vials for COVID-19 Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Vials for COVID-19 Vaccine Sale Price by Application (2019-2024)
3 GLOBAL VIALS FOR COVID-19 VACCINE BY COMPANY
3.1 Global Vials for COVID-19 Vaccine Breakdown Data by Company
3.1.1 Global Vials for COVID-19 Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Vials for COVID-19 Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Vials for COVID-19 Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Vials for COVID-19 Vaccine Revenue by Company (2019-2024)
3.2.2 Global Vials for COVID-19 Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Vials for COVID-19 Vaccine Sale Price by Company
3.4 Key Manufacturers Vials for COVID-19 Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vials for COVID-19 Vaccine Product Location Distribution
3.4.2 Players Vials for COVID-19 Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VIALS FOR COVID-19 VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Vials for COVID-19 Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Vials for COVID-19 Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Vials for COVID-19 Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Vials for COVID-19 Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Vials for COVID-19 Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Vials for COVID-19 Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Vials for COVID-19 Vaccine Sales Growth
4.4 APAC Vials for COVID-19 Vaccine Sales Growth
4.5 Europe Vials for COVID-19 Vaccine Sales Growth
4.6 Middle East & Africa Vials for COVID-19 Vaccine Sales Growth
5 AMERICAS
5.1 Americas Vials for COVID-19 Vaccine Sales by Country
5.1.1 Americas Vials for COVID-19 Vaccine Sales by Country (2019-2024)
5.1.2 Americas Vials for COVID-19 Vaccine Revenue by Country (2019-2024)
5.2 Americas Vials for COVID-19 Vaccine Sales by Type
5.3 Americas Vials for COVID-19 Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vials for COVID-19 Vaccine Sales by Region
6.1.1 APAC Vials for COVID-19 Vaccine Sales by Region (2019-2024)
6.1.2 APAC Vials for COVID-19 Vaccine Revenue by Region (2019-2024)
6.2 APAC Vials for COVID-19 Vaccine Sales by Type
6.3 APAC Vials for COVID-19 Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vials for COVID-19 Vaccine by Country
7.1.1 Europe Vials for COVID-19 Vaccine Sales by Country (2019-2024)
7.1.2 Europe Vials for COVID-19 Vaccine Revenue by Country (2019-2024)
7.2 Europe Vials for COVID-19 Vaccine Sales by Type
7.3 Europe Vials for COVID-19 Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vials for COVID-19 Vaccine by Country
8.1.1 Middle East & Africa Vials for COVID-19 Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Vials for COVID-19 Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Vials for COVID-19 Vaccine Sales by Type
8.3 Middle East & Africa Vials for COVID-19 Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vials for COVID-19 Vaccine
10.3 Manufacturing Process Analysis of Vials for COVID-19 Vaccine
10.4 Industry Chain Structure of Vials for COVID-19 Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vials for COVID-19 Vaccine Distributors
11.3 Vials for COVID-19 Vaccine Customer
12 WORLD FORECAST REVIEW FOR VIALS FOR COVID-19 VACCINE BY GEOGRAPHIC REGION
12.1 Global Vials for COVID-19 Vaccine Market Size Forecast by Region
12.1.1 Global Vials for COVID-19 Vaccine Forecast by Region (2025-2030)
12.1.2 Global Vials for COVID-19 Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vials for COVID-19 Vaccine Forecast by Type
12.7 Global Vials for COVID-19 Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Corning
13.1.1 Corning Company Information
13.1.2 Corning Vials for COVID-19 Vaccine Product Portfolios and Specifications
13.1.3 Corning Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Corning Main Business Overview
13.1.5 Corning Latest Developments
13.2 Schott AG
13.2.1 Schott AG Company Information
13.2.2 Schott AG Vials for COVID-19 Vaccine Product Portfolios and Specifications
13.2.3 Schott AG Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Schott AG Main Business Overview
13.2.5 Schott AG Latest Developments
13.3 SiO2 Materials Science
13.3.1 SiO2 Materials Science Company Information
13.3.2 SiO2 Materials Science Vials for COVID-19 Vaccine Product Portfolios and Specifications
13.3.3 SiO2 Materials Science Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 SiO2 Materials Science Main Business Overview
13.3.5 SiO2 Materials Science Latest Developments
13.4 SGD Pharma
13.4.1 SGD Pharma Company Information
13.4.2 SGD Pharma Vials for COVID-19 Vaccine Product Portfolios and Specifications
13.4.3 SGD Pharma Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 SGD Pharma Main Business Overview
13.4.5 SGD Pharma Latest Developments
13.5 Stevanato Group
13.5.1 Stevanato Group Company Information
13.5.2 Stevanato Group Vials for COVID-19 Vaccine Product Portfolios and Specifications
13.5.3 Stevanato Group Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Stevanato Group Main Business Overview
13.5.5 Stevanato Group Latest Developments
13.6 DWK Life Sciences
13.6.1 DWK Life Sciences Company Information
13.6.2 DWK Life Sciences Vials for COVID-19 Vaccine Product Portfolios and Specifications
13.6.3 DWK Life Sciences Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 DWK Life Sciences Main Business Overview
13.6.5 DWK Life Sciences Latest Developments
13.7 Gerresheimer
13.7.1 Gerresheimer Company Information
13.7.2 Gerresheimer Vials for COVID-19 Vaccine Product Portfolios and Specifications
13.7.3 Gerresheimer Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Gerresheimer Main Business Overview
13.7.5 Gerresheimer Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vials for COVID-19 Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Vials for COVID-19 Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Middle-borate Borosilicate Glass
Table 4. Major Players of Low-borate Borosilicate Glass
Table 5. Global Vials for COVID-19 Vaccine Sales by Type (2019-2024) & (Million Units)
Table 6. Global Vials for COVID-19 Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Vials for COVID-19 Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Vials for COVID-19 Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Vials for COVID-19 Vaccine Sale Price by Type (2019-2024) & (US$/K Units)
Table 10. Global Vials for COVID-19 Vaccine Sales by Application (2019-2024) & (Million Units)
Table 11. Global Vials for COVID-19 Vaccine Sales Market Share by Application (2019-2024)
Table 12. Global Vials for COVID-19 Vaccine Revenue by Application (2019-2024)
Table 13. Global Vials for COVID-19 Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Vials for COVID-19 Vaccine Sale Price by Application (2019-2024) & (US$/K Units)
Table 15. Global Vials for COVID-19 Vaccine Sales by Company (2019-2024) & (Million Units)
Table 16. Global Vials for COVID-19 Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Vials for COVID-19 Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Vials for COVID-19 Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Vials for COVID-19 Vaccine Sale Price by Company (2019-2024) & (US$/K Units)
Table 20. Key Manufacturers Vials for COVID-19 Vaccine Producing Area Distribution and Sales Area
Table 21. Players Vials for COVID-19 Vaccine Products Offered
Table 22. Vials for COVID-19 Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vials for COVID-19 Vaccine Sales by Geographic Region (2019-2024) & (Million Units)
Table 26. Global Vials for COVID-19 Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Vials for COVID-19 Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Vials for COVID-19 Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Vials for COVID-19 Vaccine Sales by Country/Region (2019-2024) & (Million Units)
Table 30. Global Vials for COVID-19 Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Vials for COVID-19 Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Vials for COVID-19 Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Vials for COVID-19 Vaccine Sales by Country (2019-2024) & (Million Units)
Table 34. Americas Vials for COVID-19 Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Vials for COVID-19 Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Vials for COVID-19 Vaccine Revenue Market Share by Country (2019-2024)
Table 37. Americas Vials for COVID-19 Vaccine Sales by Type (2019-2024) & (Million Units)
Table 38. Americas Vials for COVID-19 Vaccine Sales by Application (2019-2024) & (Million Units)
Table 39. APAC Vials for COVID-19 Vaccine Sales by Region (2019-2024) & (Million Units)
Table 40. APAC Vials for COVID-19 Vaccine Sales Market Share by Region (2019-2024)
Table 41. APAC Vials for COVID-19 Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Vials for COVID-19 Vaccine Revenue Market Share by Region (2019-2024)
Table 43. APAC Vials for COVID-19 Vaccine Sales by Type (2019-2024) & (Million Units)
Table 44. APAC Vials for COVID-19 Vaccine Sales by Application (2019-2024) & (Million Units)
Table 45. Europe Vials for COVID-19 Vaccine Sales by Country (2019-2024) & (Million Units)
Table 46. Europe Vials for COVID-19 Vaccine Sales Market Share by Country (2019-2024)
Table 47. Europe Vials for COVID-19 Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Vials for COVID-19 Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Europe Vials for COVID-19 Vaccine Sales by Type (2019-2024) & (Million Units)
Table 50. Europe Vials for COVID-19 Vaccine Sales by Application (2019-2024) & (Million Units)
Table 51. Middle East & Africa Vials for COVID-19 Vaccine Sales by Country (2019-2024) & (Million Units)
Table 52. Middle East & Africa Vials for COVID-19 Vaccine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Vials for COVID-19 Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Vials for COVID-19 Vaccine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Vials for COVID-19 Vaccine Sales by Type (2019-2024) & (Million Units)
Table 56. Middle East & Africa Vials for COVID-19 Vaccine Sales by Application (2019-2024) & (Million Units)
Table 57. Key Market Drivers & Growth Opportunities of Vials for COVID-19 Vaccine
Table 58. Key Market Challenges & Risks of Vials for COVID-19 Vaccine
Table 59. Key Industry Trends of Vials for COVID-19 Vaccine
Table 60. Vials for COVID-19 Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Vials for COVID-19 Vaccine Distributors List
Table 63. Vials for COVID-19 Vaccine Customer List
Table 64. Global Vials for COVID-19 Vaccine Sales Forecast by Region (2025-2030) & (Million Units)
Table 65. Global Vials for COVID-19 Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Vials for COVID-19 Vaccine Sales Forecast by Country (2025-2030) & (Million Units)
Table 67. Americas Vials for COVID-19 Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Vials for COVID-19 Vaccine Sales Forecast by Region (2025-2030) & (Million Units)
Table 69. APAC Vials for COVID-19 Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Vials for COVID-19 Vaccine Sales Forecast by Country (2025-2030) & (Million Units)
Table 71. Europe Vials for COVID-19 Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Vials for COVID-19 Vaccine Sales Forecast by Country (2025-2030) & (Million Units)
Table 73. Middle East & Africa Vials for COVID-19 Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Vials for COVID-19 Vaccine Sales Forecast by Type (2025-2030) & (Million Units)
Table 75. Global Vials for COVID-19 Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Vials for COVID-19 Vaccine Sales Forecast by Application (2025-2030) & (Million Units)
Table 77. Global Vials for COVID-19 Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Corning Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Corning Vials for COVID-19 Vaccine Product Portfolios and Specifications
Table 80. Corning Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 81. Corning Main Business
Table 82. Corning Latest Developments
Table 83. Schott AG Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Schott AG Vials for COVID-19 Vaccine Product Portfolios and Specifications
Table 85. Schott AG Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 86. Schott AG Main Business
Table 87. Schott AG Latest Developments
Table 88. SiO2 Materials Science Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. SiO2 Materials Science Vials for COVID-19 Vaccine Product Portfolios and Specifications
Table 90. SiO2 Materials Science Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 91. SiO2 Materials Science Main Business
Table 92. SiO2 Materials Science Latest Developments
Table 93. SGD Pharma Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. SGD Pharma Vials for COVID-19 Vaccine Product Portfolios and Specifications
Table 95. SGD Pharma Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 96. SGD Pharma Main Business
Table 97. SGD Pharma Latest Developments
Table 98. Stevanato Group Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Stevanato Group Vials for COVID-19 Vaccine Product Portfolios and Specifications
Table 100. Stevanato Group Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 101. Stevanato Group Main Business
Table 102. Stevanato Group Latest Developments
Table 103. DWK Life Sciences Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. DWK Life Sciences Vials for COVID-19 Vaccine Product Portfolios and Specifications
Table 105. DWK Life Sciences Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 106. DWK Life Sciences Main Business
Table 107. DWK Life Sciences Latest Developments
Table 108. Gerresheimer Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Gerresheimer Vials for COVID-19 Vaccine Product Portfolios and Specifications
Table 110. Gerresheimer Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 111. Gerresheimer Main Business
Table 112. Gerresheimer Latest Developments
Table 1. Vials for COVID-19 Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Vials for COVID-19 Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Middle-borate Borosilicate Glass
Table 4. Major Players of Low-borate Borosilicate Glass
Table 5. Global Vials for COVID-19 Vaccine Sales by Type (2019-2024) & (Million Units)
Table 6. Global Vials for COVID-19 Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Vials for COVID-19 Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Vials for COVID-19 Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Vials for COVID-19 Vaccine Sale Price by Type (2019-2024) & (US$/K Units)
Table 10. Global Vials for COVID-19 Vaccine Sales by Application (2019-2024) & (Million Units)
Table 11. Global Vials for COVID-19 Vaccine Sales Market Share by Application (2019-2024)
Table 12. Global Vials for COVID-19 Vaccine Revenue by Application (2019-2024)
Table 13. Global Vials for COVID-19 Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Vials for COVID-19 Vaccine Sale Price by Application (2019-2024) & (US$/K Units)
Table 15. Global Vials for COVID-19 Vaccine Sales by Company (2019-2024) & (Million Units)
Table 16. Global Vials for COVID-19 Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Vials for COVID-19 Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Vials for COVID-19 Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Vials for COVID-19 Vaccine Sale Price by Company (2019-2024) & (US$/K Units)
Table 20. Key Manufacturers Vials for COVID-19 Vaccine Producing Area Distribution and Sales Area
Table 21. Players Vials for COVID-19 Vaccine Products Offered
Table 22. Vials for COVID-19 Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vials for COVID-19 Vaccine Sales by Geographic Region (2019-2024) & (Million Units)
Table 26. Global Vials for COVID-19 Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Vials for COVID-19 Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Vials for COVID-19 Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Vials for COVID-19 Vaccine Sales by Country/Region (2019-2024) & (Million Units)
Table 30. Global Vials for COVID-19 Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Vials for COVID-19 Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Vials for COVID-19 Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Vials for COVID-19 Vaccine Sales by Country (2019-2024) & (Million Units)
Table 34. Americas Vials for COVID-19 Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Vials for COVID-19 Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Vials for COVID-19 Vaccine Revenue Market Share by Country (2019-2024)
Table 37. Americas Vials for COVID-19 Vaccine Sales by Type (2019-2024) & (Million Units)
Table 38. Americas Vials for COVID-19 Vaccine Sales by Application (2019-2024) & (Million Units)
Table 39. APAC Vials for COVID-19 Vaccine Sales by Region (2019-2024) & (Million Units)
Table 40. APAC Vials for COVID-19 Vaccine Sales Market Share by Region (2019-2024)
Table 41. APAC Vials for COVID-19 Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Vials for COVID-19 Vaccine Revenue Market Share by Region (2019-2024)
Table 43. APAC Vials for COVID-19 Vaccine Sales by Type (2019-2024) & (Million Units)
Table 44. APAC Vials for COVID-19 Vaccine Sales by Application (2019-2024) & (Million Units)
Table 45. Europe Vials for COVID-19 Vaccine Sales by Country (2019-2024) & (Million Units)
Table 46. Europe Vials for COVID-19 Vaccine Sales Market Share by Country (2019-2024)
Table 47. Europe Vials for COVID-19 Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Vials for COVID-19 Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Europe Vials for COVID-19 Vaccine Sales by Type (2019-2024) & (Million Units)
Table 50. Europe Vials for COVID-19 Vaccine Sales by Application (2019-2024) & (Million Units)
Table 51. Middle East & Africa Vials for COVID-19 Vaccine Sales by Country (2019-2024) & (Million Units)
Table 52. Middle East & Africa Vials for COVID-19 Vaccine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Vials for COVID-19 Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Vials for COVID-19 Vaccine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Vials for COVID-19 Vaccine Sales by Type (2019-2024) & (Million Units)
Table 56. Middle East & Africa Vials for COVID-19 Vaccine Sales by Application (2019-2024) & (Million Units)
Table 57. Key Market Drivers & Growth Opportunities of Vials for COVID-19 Vaccine
Table 58. Key Market Challenges & Risks of Vials for COVID-19 Vaccine
Table 59. Key Industry Trends of Vials for COVID-19 Vaccine
Table 60. Vials for COVID-19 Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Vials for COVID-19 Vaccine Distributors List
Table 63. Vials for COVID-19 Vaccine Customer List
Table 64. Global Vials for COVID-19 Vaccine Sales Forecast by Region (2025-2030) & (Million Units)
Table 65. Global Vials for COVID-19 Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Vials for COVID-19 Vaccine Sales Forecast by Country (2025-2030) & (Million Units)
Table 67. Americas Vials for COVID-19 Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Vials for COVID-19 Vaccine Sales Forecast by Region (2025-2030) & (Million Units)
Table 69. APAC Vials for COVID-19 Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Vials for COVID-19 Vaccine Sales Forecast by Country (2025-2030) & (Million Units)
Table 71. Europe Vials for COVID-19 Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Vials for COVID-19 Vaccine Sales Forecast by Country (2025-2030) & (Million Units)
Table 73. Middle East & Africa Vials for COVID-19 Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Vials for COVID-19 Vaccine Sales Forecast by Type (2025-2030) & (Million Units)
Table 75. Global Vials for COVID-19 Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Vials for COVID-19 Vaccine Sales Forecast by Application (2025-2030) & (Million Units)
Table 77. Global Vials for COVID-19 Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Corning Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Corning Vials for COVID-19 Vaccine Product Portfolios and Specifications
Table 80. Corning Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 81. Corning Main Business
Table 82. Corning Latest Developments
Table 83. Schott AG Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Schott AG Vials for COVID-19 Vaccine Product Portfolios and Specifications
Table 85. Schott AG Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 86. Schott AG Main Business
Table 87. Schott AG Latest Developments
Table 88. SiO2 Materials Science Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. SiO2 Materials Science Vials for COVID-19 Vaccine Product Portfolios and Specifications
Table 90. SiO2 Materials Science Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 91. SiO2 Materials Science Main Business
Table 92. SiO2 Materials Science Latest Developments
Table 93. SGD Pharma Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. SGD Pharma Vials for COVID-19 Vaccine Product Portfolios and Specifications
Table 95. SGD Pharma Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 96. SGD Pharma Main Business
Table 97. SGD Pharma Latest Developments
Table 98. Stevanato Group Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Stevanato Group Vials for COVID-19 Vaccine Product Portfolios and Specifications
Table 100. Stevanato Group Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 101. Stevanato Group Main Business
Table 102. Stevanato Group Latest Developments
Table 103. DWK Life Sciences Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. DWK Life Sciences Vials for COVID-19 Vaccine Product Portfolios and Specifications
Table 105. DWK Life Sciences Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 106. DWK Life Sciences Main Business
Table 107. DWK Life Sciences Latest Developments
Table 108. Gerresheimer Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Gerresheimer Vials for COVID-19 Vaccine Product Portfolios and Specifications
Table 110. Gerresheimer Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 111. Gerresheimer Main Business
Table 112. Gerresheimer Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vials for COVID-19 Vaccine
Figure 2. Vials for COVID-19 Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vials for COVID-19 Vaccine Sales Growth Rate 2019-2030 (Million Units)
Figure 7. Global Vials for COVID-19 Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Vials for COVID-19 Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Middle-borate Borosilicate Glass
Figure 10. Product Picture of Low-borate Borosilicate Glass
Figure 11. Global Vials for COVID-19 Vaccine Sales Market Share by Type in 2023
Figure 12. Global Vials for COVID-19 Vaccine Revenue Market Share by Type (2019-2024)
Figure 13. Vials for COVID-19 Vaccine Consumed in Vaccine Manufacturing
Figure 14. Global Vials for COVID-19 Vaccine Market: Vaccine Manufacturing (2019-2024) & (Million Units)
Figure 15. Vials for COVID-19 Vaccine Consumed in Vaccine Researching
Figure 16. Global Vials for COVID-19 Vaccine Market: Vaccine Researching (2019-2024) & (Million Units)
Figure 17. Global Vials for COVID-19 Vaccine Sales Market Share by Application (2023)
Figure 18. Global Vials for COVID-19 Vaccine Revenue Market Share by Application in 2023
Figure 19. Vials for COVID-19 Vaccine Sales Market by Company in 2023 (Million Units)
Figure 20. Global Vials for COVID-19 Vaccine Sales Market Share by Company in 2023
Figure 21. Vials for COVID-19 Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Vials for COVID-19 Vaccine Revenue Market Share by Company in 2023
Figure 23. Global Vials for COVID-19 Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Vials for COVID-19 Vaccine Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Vials for COVID-19 Vaccine Sales 2019-2024 (Million Units)
Figure 26. Americas Vials for COVID-19 Vaccine Revenue 2019-2024 ($ Millions)
Figure 27. APAC Vials for COVID-19 Vaccine Sales 2019-2024 (Million Units)
Figure 28. APAC Vials for COVID-19 Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. Europe Vials for COVID-19 Vaccine Sales 2019-2024 (Million Units)
Figure 30. Europe Vials for COVID-19 Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Vials for COVID-19 Vaccine Sales 2019-2024 (Million Units)
Figure 32. Middle East & Africa Vials for COVID-19 Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Americas Vials for COVID-19 Vaccine Sales Market Share by Country in 2023
Figure 34. Americas Vials for COVID-19 Vaccine Revenue Market Share by Country in 2023
Figure 35. Americas Vials for COVID-19 Vaccine Sales Market Share by Type (2019-2024)
Figure 36. Americas Vials for COVID-19 Vaccine Sales Market Share by Application (2019-2024)
Figure 37. United States Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Vials for COVID-19 Vaccine Sales Market Share by Region in 2023
Figure 42. APAC Vials for COVID-19 Vaccine Revenue Market Share by Regions in 2023
Figure 43. APAC Vials for COVID-19 Vaccine Sales Market Share by Type (2019-2024)
Figure 44. APAC Vials for COVID-19 Vaccine Sales Market Share by Application (2019-2024)
Figure 45. China Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Vials for COVID-19 Vaccine Sales Market Share by Country in 2023
Figure 53. Europe Vials for COVID-19 Vaccine Revenue Market Share by Country in 2023
Figure 54. Europe Vials for COVID-19 Vaccine Sales Market Share by Type (2019-2024)
Figure 55. Europe Vials for COVID-19 Vaccine Sales Market Share by Application (2019-2024)
Figure 56. Germany Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Vials for COVID-19 Vaccine Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Vials for COVID-19 Vaccine Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Vials for COVID-19 Vaccine Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Vials for COVID-19 Vaccine Sales Market Share by Application (2019-2024)
Figure 65. Egypt Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Vials for COVID-19 Vaccine in 2023
Figure 71. Manufacturing Process Analysis of Vials for COVID-19 Vaccine
Figure 72. Industry Chain Structure of Vials for COVID-19 Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Vials for COVID-19 Vaccine Sales Market Forecast by Region (2025-2030)
Figure 75. Global Vials for COVID-19 Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Vials for COVID-19 Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Vials for COVID-19 Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Vials for COVID-19 Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Vials for COVID-19 Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Vials for COVID-19 Vaccine
Figure 2. Vials for COVID-19 Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vials for COVID-19 Vaccine Sales Growth Rate 2019-2030 (Million Units)
Figure 7. Global Vials for COVID-19 Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Vials for COVID-19 Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Middle-borate Borosilicate Glass
Figure 10. Product Picture of Low-borate Borosilicate Glass
Figure 11. Global Vials for COVID-19 Vaccine Sales Market Share by Type in 2023
Figure 12. Global Vials for COVID-19 Vaccine Revenue Market Share by Type (2019-2024)
Figure 13. Vials for COVID-19 Vaccine Consumed in Vaccine Manufacturing
Figure 14. Global Vials for COVID-19 Vaccine Market: Vaccine Manufacturing (2019-2024) & (Million Units)
Figure 15. Vials for COVID-19 Vaccine Consumed in Vaccine Researching
Figure 16. Global Vials for COVID-19 Vaccine Market: Vaccine Researching (2019-2024) & (Million Units)
Figure 17. Global Vials for COVID-19 Vaccine Sales Market Share by Application (2023)
Figure 18. Global Vials for COVID-19 Vaccine Revenue Market Share by Application in 2023
Figure 19. Vials for COVID-19 Vaccine Sales Market by Company in 2023 (Million Units)
Figure 20. Global Vials for COVID-19 Vaccine Sales Market Share by Company in 2023
Figure 21. Vials for COVID-19 Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Vials for COVID-19 Vaccine Revenue Market Share by Company in 2023
Figure 23. Global Vials for COVID-19 Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Vials for COVID-19 Vaccine Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Vials for COVID-19 Vaccine Sales 2019-2024 (Million Units)
Figure 26. Americas Vials for COVID-19 Vaccine Revenue 2019-2024 ($ Millions)
Figure 27. APAC Vials for COVID-19 Vaccine Sales 2019-2024 (Million Units)
Figure 28. APAC Vials for COVID-19 Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. Europe Vials for COVID-19 Vaccine Sales 2019-2024 (Million Units)
Figure 30. Europe Vials for COVID-19 Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Vials for COVID-19 Vaccine Sales 2019-2024 (Million Units)
Figure 32. Middle East & Africa Vials for COVID-19 Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Americas Vials for COVID-19 Vaccine Sales Market Share by Country in 2023
Figure 34. Americas Vials for COVID-19 Vaccine Revenue Market Share by Country in 2023
Figure 35. Americas Vials for COVID-19 Vaccine Sales Market Share by Type (2019-2024)
Figure 36. Americas Vials for COVID-19 Vaccine Sales Market Share by Application (2019-2024)
Figure 37. United States Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Vials for COVID-19 Vaccine Sales Market Share by Region in 2023
Figure 42. APAC Vials for COVID-19 Vaccine Revenue Market Share by Regions in 2023
Figure 43. APAC Vials for COVID-19 Vaccine Sales Market Share by Type (2019-2024)
Figure 44. APAC Vials for COVID-19 Vaccine Sales Market Share by Application (2019-2024)
Figure 45. China Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Vials for COVID-19 Vaccine Sales Market Share by Country in 2023
Figure 53. Europe Vials for COVID-19 Vaccine Revenue Market Share by Country in 2023
Figure 54. Europe Vials for COVID-19 Vaccine Sales Market Share by Type (2019-2024)
Figure 55. Europe Vials for COVID-19 Vaccine Sales Market Share by Application (2019-2024)
Figure 56. Germany Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Vials for COVID-19 Vaccine Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Vials for COVID-19 Vaccine Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Vials for COVID-19 Vaccine Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Vials for COVID-19 Vaccine Sales Market Share by Application (2019-2024)
Figure 65. Egypt Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Vials for COVID-19 Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Vials for COVID-19 Vaccine in 2023
Figure 71. Manufacturing Process Analysis of Vials for COVID-19 Vaccine
Figure 72. Industry Chain Structure of Vials for COVID-19 Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Vials for COVID-19 Vaccine Sales Market Forecast by Region (2025-2030)
Figure 75. Global Vials for COVID-19 Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Vials for COVID-19 Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Vials for COVID-19 Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Vials for COVID-19 Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Vials for COVID-19 Vaccine Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Machine Screws Market Growth 2025-2031
US$ 3,660.00
December 2024
90 pages
Global Squeeze Casting Machine Market Growth 2025-2031
US$ 3,660.00
January 2025
112 pages
Global Whole-House Tankless Electric Water Heater Market Growth 2024-2030
US$ 3,660.00
June 2024
97 pages
